Literature DB >> 19887788

Estimating glomerular filtration rate using the new CKD-EPI equation and other equations in patients with autosomal dominant polycystic kidney disease.

Bjarne Orskov1, Malene L Borresen, Bo Feldt-Rasmussen, Ole Østergaard, Inga Laursen, Svend Strandgaard.   

Abstract

BACKGROUND: No studies have compared the performance of equations for estimating glomerular filtration rate (GFR) in patients with autosomal dominant polycystic kidney disease (ADPKD), where the declining GFR typically is followed for many years or even decades. This was the purpose of the present investigation.
METHODS: 101 ADPKD patients with chronic kidney disease stages 1-5 were recruited and GFR was measured with the (51)Cr-EDTA clearance method, and estimated with the Modification of Diet in Renal Disease Study (MDRD) equation with 4 variables, the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation, the Cockcroft-Gault equation adjusted for body surface area and the MDRD equation with cystatin C. Performance was evaluated by mean bias, precision and accuracy.
RESULTS: The MDRD equation with cystatin C had 97% of GFR estimates within 30% of measured GFR (accuracy). Both the CKD-EPI and Cockcroft-Gault equations had an accuracy of 90% whereas the MDRD equation had an accuracy of 83%. This difference of accuracy was especially marked with GFR >60 ml/min/1.73 m(2).
CONCLUSION: For estimating GFR in ADPKD patients the MDRD equation with cystatin C incorporated had the best performance. The CKD-EPI or the Cockcroft-Gault equations showed better performance compared to the 4-variable MDRD equation. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19887788     DOI: 10.1159/000256657

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  16 in total

1.  Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Arlene B Chapman; Olivier Devuyst; Kai-Uwe Eckardt; Ron T Gansevoort; Tess Harris; Shigeo Horie; Bertram L Kasiske; Dwight Odland; York Pei; Ronald D Perrone; Yves Pirson; Robert W Schrier; Roser Torra; Vicente E Torres; Terry Watnick; David C Wheeler
Journal:  Kidney Int       Date:  2015-03-18       Impact factor: 10.612

2.  Optimal equation for estimation of glomerular filtration rate in autosomal dominant polycystic kidney disease: influence of tolvaptan.

Authors:  Tsuyoshi Yamaguchi; Eiji Higashihara; Takatsugu Okegawa; Isao Miyazaki; Kikuo Nutahara
Journal:  Clin Exp Nephrol       Date:  2018-05-22       Impact factor: 2.801

3.  Safety study of somatostatin analogue octreotide for autosomal dominant polycystic kidney disease in Japan.

Authors:  Eiji Higashihara; Kikuo Nutahara; Takatsugu Okegawa; Mitsuhiro Tanbo; Hideaki Mori; Isao Miyazaki; Toshiaki Nitatori; Kuninori Kobayashi
Journal:  Clin Exp Nephrol       Date:  2014-10-29       Impact factor: 2.801

4.  Performance of the CKD-EPI Equation to Estimate GFR in a Longitudinal Study of Autosomal Dominant Polycystic Kidney Disease.

Authors:  Chengli Shen; Douglas Landsittel; María V Irazabal; Alan S L Yu; Arlene B Chapman; Michal Mrug; Jared J Grantham; Kyongtae T Bae; William M Bennett; Michael F Flessner; Vicente E Torres
Journal:  Am J Kidney Dis       Date:  2016-12-24       Impact factor: 8.860

5.  Estimated GFR in autosomal dominant polycystic kidney disease: errors of an unpredictable method.

Authors:  Rosa Miquel Rodríguez; Sergio Luis-Lima; Juan Manuel Fernandez; María Vanesa Pérez Gómez; Beatriz González Toledo; Marian Cobo; Patricia Delgado-Mallén; Beatriz Escamilla; Cristina Oramas Marco; Sara Estupiñán; Coriolano Cruz Perera; Natalia Negrín Mena; Laura Díaz Martín; Sergio Pitti Reyes; Ibrahim Hernández González; Federico González-Rinne; Alejandra González-Delgado; Carmen Ferrer-Moure; Begoña López-Botet Zulueta; Armando Torres; Jose Carlos Rodriguez Pérez; Flavio Gaspari; Alberto Ortiz; Esteban Porrini
Journal:  J Nephrol       Date:  2022-03-31       Impact factor: 4.393

6.  Renal disease progression in autosomal dominant polycystic kidney disease.

Authors:  Eiji Higashihara; Shigeo Horie; Satoru Muto; Toshio Mochizuki; Saori Nishio; Kikuo Nutahara
Journal:  Clin Exp Nephrol       Date:  2012-04-21       Impact factor: 2.801

7.  Measuring and estimating GFR and treatment effect in ADPKD patients: results and implications of a longitudinal cohort study.

Authors:  Piero Ruggenenti; Flavio Gaspari; Antonio Cannata; Fabiola Carrara; Claudia Cella; Silvia Ferrari; Nadia Stucchi; Silvia Prandini; Bogdan Ene-Iordache; Olimpia Diadei; Norberto Perico; Patrizia Ondei; Antonio Pisani; Erasmo Buongiorno; Piergiorgio Messa; Mauro Dugo; Giuseppe Remuzzi
Journal:  PLoS One       Date:  2012-02-28       Impact factor: 3.240

Review 8.  Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice.

Authors:  Ron T Gansevoort; Mustafa Arici; Thomas Benzing; Henrik Birn; Giovambattista Capasso; Adrian Covic; Olivier Devuyst; Christiane Drechsler; Kai-Uwe Eckardt; Francesco Emma; Bertrand Knebelmann; Yannick Le Meur; Ziad A Massy; Albert C M Ong; Alberto Ortiz; Franz Schaefer; Roser Torra; Raymond Vanholder; Andrzej Więcek; Carmine Zoccali; Wim Van Biesen
Journal:  Nephrol Dial Transplant       Date:  2016-01-29       Impact factor: 5.992

9.  Cystatin C estimated glomerular filtration rate to assess renal function in early stages of autosomal dominant polycystic kidney disease.

Authors:  Laia Sans; Aleksandar Radosevic; Claudia Quintian; Rosario Montañés; Silvia Gràcia; Carles Vilaplana; Sergi Mojal; José A Ballarin; Patricia Fernández-Llama; Roser Torra; Julio Pascual
Journal:  PLoS One       Date:  2017-03-27       Impact factor: 3.240

10.  Does increased water intake prevent disease progression in autosomal dominant polycystic kidney disease?

Authors:  Eiji Higashihara; Kikuo Nutahara; Mitsuhiro Tanbo; Hidehiko Hara; Isao Miyazaki; Kuninori Kobayashi; Toshiaki Nitatori
Journal:  Nephrol Dial Transplant       Date:  2014-04-15       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.